Skip to main content

Table 1 Summary of changes in clinical outcome measures for individuals with baseline and first follow-up assessment

From: ‘Work it out’: evaluation of a chronic condition self-management program for urban Aboriginal and Torres Strait Islander people, with or at risk of cardiovascular disease

Clinical Outcome Measure n Mean Change (95% CI) Baseline Measurement (SD) Follow-up Measurement (SD) p-value†
Weight (kg) 65 −0.57 (−1.28, 0.14) 98.90 (27.97) 98.32 (27.65) 0.113
Weight within BMI Groups (kg)
Healthy ≤10 0.26 (−3.30, 3.82) 66.53 (7.84) 66.80 (8.13)
Overweight ≥10 −0.02 (−1.12, 1.08) 76.35 (9.76) 76.33 (10.40) 0.974
Obese I 15 −1.21 (−3.11, 0.69) 92.39 (12.37) 91.17 (11.11) 0.194
Obese II 12 0.85 (−0.46, 2.15) 95.64 (9.67) 96.48 (9.67) 0.181
Extreme Obesity 19 −1.57 (−3.03, −0.10) 130.55 (27.23) 128.98 (28.09) 0.037*
BMI (kg/m2) 64 −0.20 (−0.47, 0.07) 35.85 (8.92) 35.65 (8.80) 0.15
Systolic BP (mmHg) 58 −0.71 (−4.85, 3.43) 128.21 (16.84) 127.50 (16.31) 0.734
Systolic BP within BP Categories (mmHg)
Normal ≥10 8.19 (3.45, 12.93) 110.29 (6.41) 118.48 (10.06) 0.002*
High/Normal ≥10 −0.79 (−8.17, 6.59) 129.21 (4.88) 128.42 (14.82) 0.825
High 18 −11.00 (−18.82, −3.18) 148.06 (7.87) 137.06 (18.49) 0.009*
Diastolic BP (mmHg) 58 −0.12, (−3.49, 3.25) 80.50 (10.17) 80.38 (11.29) 0.943
Diastolic BP within BP Categories (mmHg)
Normal ≥10 5.31 (1.59, 9.04) 73.63 (6.65) 78.94 (9.55) 0.007*
High/Normal ≥10 −5.87 (−13.48, 1.74) 85.13 (2.87) 79.25 (13.88) 0.121
High 9 −8.11 (−16.08, −0.14) 93.33 (4.06) 85.22 (10.12)
Waist circumference (cm) 60 −0.58 (−3.06, 1.89) 116.32 (19.86) 115.73 (18.98) 0.63
Waist circumference within Waist circumference groups (cm)
No increased risk ≤10 5.33 (−5.01, 15.68) 93.66 (10.06) 88.33 (8.08)
Increased risk ≤10 1.77 (−14.15, 17.69) 84.07 (3.00) 85.83 (4.54)
Substantially increased risk 54 −1.05 (−3.74, 1.65) 119.7 (17.94) 118.62 (17.61) 0.44
Hip circumference (cm) 57 −0.65 (−2.55, 1.25) 123.57 (18.39) 122.9 (19.80) 0.49
WHR (waist/hip) 57 0.0007 (−0.024, 0.025) 0.94 (0.093) 0.95 (0.091) 0.95
WHR within WHR Groups (waist/hip)
No increased risk ≤10 0.108 (−0.001, 0.219) 0.81 (0.022) 0.92 (0.12)
Substantially increased risk ≥10 −0.016 (−0.038, 0.004) 0.97 (0.080) 0.95 (0.086) 0.12
6MWT (km) 47 0.053 (0.01, 0.07) 0.38 (0.18) 0.43 (0.16) 0.023*
  1. † Paired t-test used to compare baseline and follow-up measurement. Statistical testing only conducted when n > 10 in each group
  2. *Significant at p < 0.05